Richard Schulz

Professor, Faculty of Medicine & Dentistry - Pediatrics Dept

Contact Overview Publications

Contact

Professor, Faculty of Medicine & Dentistry - Pediatrics Dept

Email: rschulz@ualberta.ca
Phone: (780) 492-6581
Address: 462 Heritage Medical Research Centre
11207 - 87 Ave NW

Edmonton AB

T6G 2S2

Overview

Area of Study / Keywords

About

Dr. Richard Schulz is currently appointed as Professor, Prof/Cardiovascular Rsch Group in the Department of Pediatrics in the Faculty of Medicine & Dentistry.

Featured Publications

Loss of Mitochondrial Dynamics Proteins Mitofusin-2 and Drp-1 in Myocardial Ischemia-Reperfusion Injury Is Prevented by Matrix Metalloproteinase-2 Preferring Inhibitors

FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2022 May; 10.1096/fasebj.2022.36.S1.R2993

RPI-194 is a Novel Troponin Activator that Increases the Calcium Sensitivity of Striated Muscle Contraction

FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2022 May; 10.1096/fasebj.2022.36.S1.0R342

Matrix metalloproteinase-2 inhibition in acute ischemia-reperfusion heart injury�cardioprotective properties of carvedilol

Skrzypiec-Spring M., Urbaniak J., Sapa-Wojciechowska A., Pietkiewicz J., Orda A., Karolko B., Danielewicz R., Bil-Lula I., Wozniak M., Schulz R., Szelag A.

Pharmaceuticals. 2021 December; 14 (15) 10.3390/ph14121276

Matrix metalloproteinase-2 mediates ribosomal RNA transcription by cleaving nucleolar histones

Ali M.A.M., Garcia-Vilas J.A., Cromwell C.R., Hubbard B.P., Hendzel M.J., Schulz R. First author is trainee

FEBS Journal. 2021 December; 288 (23):6736-6751 10.1111/febs.16061

Multifunctional intracellular matrix metalloproteinases: implications in disease

Bassiouni W., Ali M.A.M., Schulz R.

FEBS Journal. 2021 December; 288 (24):7162-7182 10.1111/febs.15701

MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin

Parente J.M., Blascke de Mello M.M., Silva P.H.L.d., Omoto A.C.M., Pernomian L., Oliveira I.S.d., Mahmud Z., Fazan R., Arantes E.C., Schulz R., Castro M.M.d.

BIOCHEMICAL PHARMACOLOGY. 2021 November; 193 10.1016/j.bcp.2021.114744

Staurosporine-induced cleavage of apoptosis-inducing factor in human fibrosarcoma cells is independent of matrix metalloproteinase-2

Bassiouni W., Seubert J.M., Schulz R.

Canadian Journal of Physiology and Pharmacology. 2021 October; 100 (2):184-191 10.1139/cjpp-2021-0199

Letter by Hwang et al Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin after Brief Induced Coronary Artery Balloon Occlusion in Humans"

Hwang P., Schulz R., Kavsak P.

CIRCULATION. 2021 August; 2021 (144):E166-E167 10.1161/CIRCULATIONAHA.121.055413

Letter by Hwang et al Regarding Article, "temporal Release of High-Sensitivity Cardiac Troponin T and i and Copeptin after Brief Induced Coronary Artery Balloon Occlusion in Humans"

Hwang P., Schulz R., Kavsak P.

CIRCULATION JOURNAL. 2021 January; 10.1161/CIRCULATIONAHA.121.055413

MMP Inhibitors Attenuate Doxorubicin Cardiotoxicity by Preventing Intracellular and Extracellular Matrix Remodeling

CHAN, B.Y.H., ROCZKOWSKY, A., CHO, W-J., POIRIER, M., SERGI, C., KESCHRUMRUS, V., CHURKO, J.M., GRANZIER, H., and SCHULZ, R

CARDIOVASCULAR RESEARCH. 2021 January; 117 10.1093/cvr/cvaa017

MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling

Chan B.Y.H., Roczkowsky A., Cho W.J., Poirier M., Sergi C., Keschrumrus V., Churko J.M., Granzier H., Schulz R.

CARDIOVASCULAR RESEARCH. 2021 January; 117 (1):188-200 10.1093/cvr/cvaa017

Staurosporine-induced cleavage of apoptosis-inducing factor in human fibrosarcoma cells is independent of matrix metalloproteinase-2

Bassiouni W., Seubert J.M., Schulz R.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. 2021 January; 100 (2):184-191 10.1139/cjpp-2021-0199